Dr Phillip Altman - AMPS Medico Legal Summit 2022

Dr Altman is a well-known Australian authority on clinical trials and regulatory affairs with more than 40 years of experience in designing, managing and reporting of clinical trials and in working with the Australian Therapeutic Goods Administration in gaining new drug approvals.

He established Australia’s first contract research organisations (CROs), where he served as a Senior Industry Consultant for more than half of the pharmaceutical companies present in Australia. His career has seen him involved in more than one hundred clinical trials (Phase I through IV). He has been personally responsible for the market approval of numerous new drugs since joining the pharmaceutical industry in 1974.

A graduate of Sydney University with an Honours degree in Pharmacy, Master of Science and Doctor of Philosophy degrees (focusing on drug development, pharmacology and pharmaceutical chemistry), he co-founded and is a Life Member of the largest professional body of pharmaceutical industry scientists involved in clinical research and regulatory affairs.

More recently Dr. Altman was a Director and the chief clinical trial and regulatory advisor for a public company involved in the development of a live virus for the treatment of late stage melanoma.

More recently Dr. Altman has provided expert reports in relation to both the Australian and NZ Judicial Review and High Court cases in relation to the Covid vaccines. Please welcome Dr Altman.